true

Additional Features
Latest news
BD logo
Jul 31, 2026

BD (Becton, Dickinson and Company) is voluntarily recalling specific lots of BD® Intraosseous Vascular Access System Needle Sets to the user level. These...

Jul 29, 2026

Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients. FRANKLIN LAKES, N.J....

BD logo
Jul 28, 2026

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common...

All news ›

Blog
Jul 28, 2026

I’m proud to share the recent launch of BD’s 2025 Sustainability Report, a reflection of the meaningful progress we have made in delivering on our purpose of advancing the world of health. ....

Jul 9, 2026

First-ever disease focused fellowship program supports specialized endovascular training for physicians across Europe By Jane Hart, VP of Clinical Affairs, BD Interventional – Peripheral...

May 11, 2026

How PPAEMA and DEA guidance support secure, accountable medication management for EMS When seconds matter, emergency medical services (EMS) professionals must be empowered to provide lifesaving...

More »